FDA — authorised 29 April 1974
- Application: NDA017441
- Marketing authorisation holder: ALLERGAN
- Local brand name: INFED
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA authorised IV iron dextran on 29 April 1974
Yes. FDA authorised it on 29 April 1974.
ALLERGAN holds the US marketing authorisation.